Compliance Insight
Compliance Insight is a trusted partner in the life sciences industry, helping businesses overseen by the FDA navigate the regulatory process, achieve compliance, and develop best practices for the manufacture of innovative drugs, medical devices, biologics, and now integrating advanced AI solutions. They offer a comprehensive suite of compliance services, including guidance on AI and digital transformation in pharma and medical device manufacturing, shaping their practice to meet client needs, providing excellent service through every development phase.
Industries
Nr. of Employees
medium (51-250)
Compliance Insight
Cincinnati, Ohio, United States, North America
Products
AI in Action for Manufacturing Process Improvement (whitepaper)
Technical whitepaper describing case examples and implementation considerations for AI applications in manufacturing process improvement.
White papers and technical guides collection
Collection of expert-authored white papers and guides covering data quality for AI, GxP topics and regulatory considerations.
GxP Infusion training modules (spaced-repetition e-learning)
Short narrated presentation modules with leader guides designed for spaced-repetition reinforcement of GxP/GMP topics for staff meetings and training sessions.
AI in Action for Manufacturing Process Improvement (whitepaper)
Technical whitepaper describing case examples and implementation considerations for AI applications in manufacturing process improvement.
White papers and technical guides collection
Collection of expert-authored white papers and guides covering data quality for AI, GxP topics and regulatory considerations.
GxP Infusion training modules (spaced-repetition e-learning)
Short narrated presentation modules with leader guides designed for spaced-repetition reinforcement of GxP/GMP topics for staff meetings and training sessions.
Services
End-to-end consulting to develop regulatory strategy, compliance programs and interaction support for FDA and related regulatory authorities.
Assessment and corrective action planning to address inspection observations and formal enforcement actions, including support during inspections.
Perform GxP audits, gap analyses, supplier and facility assessments and provide virtual QA services including remote document and system review.
Consulting to identify AI use cases, centralize regulated data, develop compliant analytics pipelines and deploy predictive models for process improvements and quality control.
Develop digital twin models and simulations to predict bioprocess behavior, optimize operations and support control strategies.
Custom workshops and short e-learning modules on GMP fundamentals, good supply practices and practical aspects of AI/ML implementation in regulated manufacturing.
End-to-end consulting to develop regulatory strategy, compliance programs and interaction support for FDA and related regulatory authorities.
Assessment and corrective action planning to address inspection observations and formal enforcement actions, including support during inspections.
Perform GxP audits, gap analyses, supplier and facility assessments and provide virtual QA services including remote document and system review.
Consulting to identify AI use cases, centralize regulated data, develop compliant analytics pipelines and deploy predictive models for process improvements and quality control.
Develop digital twin models and simulations to predict bioprocess behavior, optimize operations and support control strategies.
Custom workshops and short e-learning modules on GMP fundamentals, good supply practices and practical aspects of AI/ML implementation in regulated manufacturing.
Expertise Areas
- Regulatory compliance and inspection readiness for FDA-regulated products
- GxP quality systems, remediation and culture change
- AI/ML adoption for manufacturing and process optimization
- Data governance and data integrity for regulated datasets
Key Technologies
- Artificial intelligence and machine learning
- Deep learning and natural language processing (NLP)
- Digital twins and asset performance modeling
- Computer vision and machine-vision inspection
News & Updates
Analysis of FDA inspection findings, including those related to AI and digital health.
Summary of FDA 483 observations for FY 2024, with emphasis on AI and digital systems.
Insights into GMP training failures and solutions, including digital and AI training modules.
An article discussing hidden risks in organizational culture that can lead to FDA findings, including those related to AI and digital systems.
Details on the FDA 483 observations for the fiscal year 2024, with focus on digital and AI systems.
An article explaining the shortcomings of traditional GMP training and alternative approaches including digital modules.
Analysis of FDA inspection findings, including those related to AI and digital health.
Summary of FDA 483 observations for FY 2024, with emphasis on AI and digital systems.
Insights into GMP training failures and solutions, including digital and AI training modules.
An article discussing hidden risks in organizational culture that can lead to FDA findings, including those related to AI and digital systems.
Details on the FDA 483 observations for the fiscal year 2024, with focus on digital and AI systems.
An article explaining the shortcomings of traditional GMP training and alternative approaches including digital modules.